Monte Financial Group, LLC Gilead Sciences, Inc. Transaction History

Monte Financial Group, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$60.0 - $68.46 $3.12 Million - $3.56 Million	-52,026 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $198,614 - $226,312	-3,506 Reduced 6.31%	52,026 $3.03 Million
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $272,060 - $342,068	4,381 Added 8.56%	55,532 $3.51 Million
Q2 2020 Aug 03, 2020	BUY	$72.34 - $84.0 $240,458 - $279,216	3,324 Added 6.95%	51,151 $3.94 Million
Q1 2020 Apr 28, 2020	SELL	$62.63 - $80.22 $887,091 - $1.14 Million	-14,164 Reduced 22.85%	47,827 $3.58 Million
Q4 2019 Feb 04, 2020	BUY	$61.62 - $67.78 $404,103 - $444,501	6,558 Added 11.83%	61,991 $4.03 Million
Q3 2019 Nov 06, 2019	BUY	$62.51 - $69.0 $134,646 - $148,626	2,154 Added 4.04%	55,433 $3.51 Million
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $188,208 - $211,053	3,042 Added 6.06%	53,279 $3.6 Million
Q1 2019 Apr 23, 2019	BUY	$62.53 - $70.05 $383,871 - $430,036	6,139 Added 13.92%	50,237 $3.27 Million
Q4 2018 Jan 31, 2019	BUY	$60.54 - $79.0 $58,118 - $75,840	960 Added 2.23%	44,098 $2.76 Million
Q3 2018 Oct 16, 2018	BUY	$71.28 - $78.92 $254,398 - $281,665	3,569 Added 9.02%	43,138 $3.33 Million
Q2 2018 Oct 16, 2018	BUY	$64.88 - $75.68 $121,779 - $142,051	1,877 Added 4.98%	39,569 $2.8 Million
Q1 2018 Oct 16, 2018	BUY	$72.84 - $88.8 $113,484 - $138,350	1,558 Added 4.31%	37,692 $2.84 Million
Q4 2017 Oct 16, 2018	BUY	$71.15 - $83.52 $2.57 Million - $3.02 Million	36,134	36,134 $2.59 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Monte Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Monte Financial Group, LLC with notifications on news.